Latest Cooper Companies quarterly has quite a bit of commentary on Misight and interest from analysts in the myopia market. Some of the highlights:
- Quarterly revenue for Misight now US$24M (below is the revenue statement)
- Misight starting to take business from the Ortho-K offerings - suggests parents like soft contact lenses more than the overnight option
- Europe is picking up
- Being the only FDA approved product is very important to them.
Misight will clearly generate greater than US$100M in revenue for 2024. Just imagine what a better product could do once FDA approval is gained.
Misight vs Naturalvue, page-14
Add VTI (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
14.0¢ |
Change
0.010(7.69%) |
Mkt cap ! $7.705M | |||
| Open | High | Low | Value | Volume |
| 14.0¢ | 14.0¢ | 14.0¢ | $33.08K | 236.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 27280 | 11.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 15.0¢ | 53763 | 2 |
View Market Depth
| Last trade - 15.57pm 30/05/2024 (20 minute delay) ? |
|
|||||
|
Last
14.0¢ |
Change
0.010 ( 12.0 %) |
||||
| Open | High | Low | Volume | ||
| 14.5¢ | 14.5¢ | 14.0¢ | 9472 | ||
| Last updated 14.29pm 30/05/2024 ? | |||||
| VTI (ASX) Chart |